| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |